October 2012 — Solazyme, located in South San Francisco, California has subscribed to R&D Logic software and services as the corporate-wide solution for collecting, managing and reporting project effort, FTEs as well as time off. Solazyme has pioneered an industrial biotechnology platform that harnesses the prolific oil-producing ability of microalgae.

September 2012 — Pfenex, located in San Diego, California, has subscribed to R&D Logic software and services for managing planning, tracking, analysis and consolidation reporting. Pfenex is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars.

August 2012 — EnVivo, located in Watertown, Massachusetts, has subscribed to R&D Logic software and services for managing FP&A corporate processes. EnVivo is developing its broad pipeline of diverse programs with a focus on leveraging novel mechanisms of action to treat CNS diseases like schizophrenia and Alzheimer’s disease in new ways and from multiple angles.

June 2012 — Epizyme, located in Cambridge, Massachusetts, has subscribed to R&D Logic software and services for planning, tracking, time collection and consolidated reporting of the R&D Portfolio and of Corporate Financials. Epizyme is leading the discovery and development of small molecule histone methyltransferase(HMT)inhibitors, a new class of personalized therapeutics for the treatment of patients with genetically-defined cancers, based on breakthroughs in the field of epigenetics.

June 2012 — AVEO, located in Cambridge, Massachusetts, has subscribed to R&D Time software services to manage time collection, FTE and collaborations reporting. AVEO Oncology is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives.

January 2012 — OncoGenex, located in Vancouver, Canada and Seattle, Washington, has subscribed to R&D Logic software and services for planning and tracking, and financial reporting. OncoGenex Pharmaceuticals is a drug discovery and development company uniquely focused on the challenge of cancer treatment resistance.

September 2011 — RealD, located in Beverly Hills, California, has subscribed to R&D Logic software services to manage planning, tracking and time collection for their Colorado based Research & Development division. RealD is a leading global licensor of stereoscopic (three-dimensional), or 3D, technologies. Its extensive intellectual property portfolio enables a premium 3D viewing experience in the theater, the home and elsewhere.

September 2011 — Vitapath Genetics, Inc., located in Foster City, California, has subscribed to R&D Logic software services to manage planning, tracking, time collection and corporate reporting. VitaPath Genetics is developing a family of DNA tests to help individuals reduce the risk of serious and life-threatening disease.

August 2011 — Affymax, located in Palo Alto, California, has subscribed to R&D Time software services to manage time collection, FTE and collaborations reporting. Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions.The company’s product candidate, peginesatide (formerly known as HematideTM), has been investigated in Phase 3 trials for the potential treatment of anemia associated with chronic renal failure.

May 2011 — NovaBay, located in Emeryville, California, has subscribed to R&D Time software services to manage time collection and collaborations' reporting. NovaBay is a clinical stage biotechnology company focused on developing its proprietary and patented topical Aganocide compounds.

November 2010 — Anthera, located in Hayward, California, has subscribed to R&D Logic software and services for planning and tracking, and financial reporting. Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious illnesses, including cardiovascular and autoimmune diseases.

October 2010 — Adamas, a long term customer of R&D Logic, has added R&D Time to their suite of services. R&D Time is being utilized to collecting and tracking time effort, with an emphasys on NIH grants. Adamas Pharmaceuticals is an emerging pharmaceutical company focused on developing small molecule Advantaged Therapeutics. Adamas Pharmaceuticals is headquartered in Emeryville, California, with operations in Bangalore, India.

September 2010 — Trius Therapeutics, located in San Diego, California, has chosen R&D Logic software for corporate and research contracts planning and tracking, budgeting and forecasting. Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections.

September 2010 — Athersys, located in Cleveland, Ohio, has subscribed to R&D Logic software and services for corporate planning and tracking, and financial reporting. Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. Through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas.

June 2010 — Prognosys Biosciences, located in La Jolla, California, has chosen R&D Logic software for corporate planning and tracking, financial reporting, and time collection. Prognosys is an early-stage biotechnology company focusing on the promising and rapidly developing field of personalized medicine. Prognosys carries out R&D in the area of novel assays and biomarker discovery, and uses next-generation sequencing technologies for the analysis of complex systems.

May 2010 — Hyperion Therapeutics, Inc., located in South San Francisco, California, has subscribed to R&D Logic software services to manage planning and tracking of corporate revenues, expenses and resources. Hyperion Therapeutics is a privately held pharmaceutical company focused on the development of treatments that address critical unmet needs in the areas of gastroenterology and hepatology.

November 2009 — MacroGenics, Inc., located in Rockville, Maryland, has subscribed to R&D Logic software services to manage world-wide corporate planning and tracking,budgeting and forecasting, and financial reporting. MacroGenics'mission is to discover, develop and deliver to patients novel biologics for the treatment of autoimmune disorders, cancer and infectious diseases.

November 2009 — Facet Biotech, located in Redwood City, California, has subscribed to R&D Time software services to manage corporate budgeting and forecasting, time collection, and project FTE reporting. Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc. Combining expertise in antibody engineering with a disciplined, biology-driven research approach, Facet Biotech is dedicated to advancing our current pipeline of four clinical-stage products and leveraging our research and development capabilities to identify and develop new drugs.

October 2009 — Inviragen, Inc.located in Fort Collins, Colorado, has subscribed to R&D Time software services to manage world-wide time collection and grant reporting. Inviragen is focused on developing life-saving vaccines to protect against emerging infectious diseases worldwide.

June 2009 — KaloBios Pharmaceuticals, located in South San Francisco, California, has subscribed to R&D Time software services to manage corporate time collection and project FTE reporting.KaloBios uses its biologic capabilities and its proprietary platform technology to develop first-in-class human antibody therapeutics.